Results 71 to 80 of about 393,422 (164)
Neuroendocrine neoplasms of the pancreas: diagnosis and pitfalls
Common to neuroendocrine neoplasms of the pancreas is their expression of synaptophysin, chromogranin A, and/or INSM1. They differ, however, in their histological differentiation and molecular profile.
Kasajima, Atsuko +3 more
core +1 more source
Multi-omic profiles of neuroendocrine neoplasms of the pancreas: an integrated landscape
Pancreatic neuroendocrine neoplasms (PanNENs) constitute a heterogeneous group of tumors distinguished by substantial variability in morphology, immunophenotype, molecular characteristics, and clinical behavior.
Michele Bevere +26 more
doaj +1 more source
Metachronous occurrence of acute myeloid leukaemia in a case of neuroendocrine tumour
Haematological neoplasms are rare in patients undergoing peptide receptor radionuclide therapy (PRRT) for neuroendocrine neoplasms, though the long-term effects on bone marrow function remain an area of interest.
Abhinav Menon +6 more
doaj +1 more source
Diabetes in Patients With Pancreatic Neuroendocrine Neoplasms
ObjectiveDiabetes mellitus (DM) is probably a risk factor for pancreatic neuroendocrine neoplasms (PNENs). However, the prevalence of DM in PNEN patients remains inconclusive.
Xiaoling Zhuge +3 more
doaj +1 more source
Neuroendocrine neoplasms of the small bowel and pancreas [PDF]
The traditionally promulgated perspectives of neuroendocrine neoplasms as rare, indolent tumours are blunt and have been outdated for the last two decades.
Frilling, Andrea +18 more
core +1 more source
Calcitonin-secreting pancreatic neuroendocrine tumor: A case report and literature review
Calcitonin-secreting is rare in patients with pancreatic neuroendocrine carcinoma, which is prone to misdiagnosis and needs more attention from clinicians.
Hongyu Wang +4 more
doaj +1 more source
Pancreatic Neuroendocrine Microtumors (WHO 2022) Are Not Always Low-Grade Neoplasms: A Case with a Highly Increased Proliferation Rate. [PDF]
Traditionally considered non-functional low proliferative benign neuroendocrine proliferations measuring less than 5 mm, pancreatic (neuro)endocrine microadenomas are now classified as pancreatic neuroendocrine microtumors in the 2022 WHO classification ...
Jirásek, Tomáš +5 more
core +2 more sources
BACKGROUND: Radiomics is currently a promising and prospective tool for diagnosing and treating neuroendocrine neoplasms at various sites. This method is often used for differential diagnosis of gastrointestinal neuroendocrine tumors with other neoplasms
Nikolay V. Nudnov +4 more
doaj +1 more source
Imaging Methods for Pancreatic Neoplasms
Imaging of pancreatic neoplasms is complex and insidious, requiring a deep knowledge of radiological techniques but also a very thorough knowledge of pancreatic pathology, its management, its risk factors, and possible complications.
Calbi, Roberto +7 more
core +1 more source
EUS-Guided Radiofrequency Ablation Therapy for Pancreatic Neoplasia
Radiofrequency ablation (RFA) under endoscopic ultrasound (EUS) guidance has been developed and utilized over the last decade to provide the loco-regional treatment of solid and cystic pancreatic neoplastic lesions.
Mihai Rimbaș +3 more
doaj +1 more source

